Braveheart Bio, Inc. (BRVE)
29.20
+1.49
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
28.95
-0.25
(-0.86%)
After-Hours: 20:00
Braveheart Bio Market Cap : 2.629B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.629B |
| September 17, 2026 | 2.495B |
| September 16, 2026 | 2.472B |
| September 15, 2026 | 2.405B |
| September 14, 2026 | 2.433B |
| Date | Value |
|---|---|
| September 11, 2026 | 2.399B |
| September 10, 2026 | 2.454B |
| September 09, 2026 | 2.603B |
| September 08, 2026 | 2.648B |
| September 04, 2026 | 2.408B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 128.83B |
| ANI Pharmaceuticals, Inc. | 1.749B |
| Corcept Therapeutics, Inc. | 11.90B |
| Veru, Inc. | 41.09M |
| IGC Pharma, Inc. | 29.19M |
Market Cap Related Metrics
| Price | 29.20 |
| Earnings Yield | -1.27% |